Caption Management, LLC Fate Therapeutics Inc Call Options Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$3.54 - $8.35 $354,000 - $835,000	100,000 New	100,000 $734,000
Q4 2021 Feb 11, 2022	SELL	$47.84 - $64.34 $1.44 Million - $1.93 Million	-30,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$67.25 - $92.52 $2.02 Million - $2.78 Million	30,000 New	30,000 $2.6 Million
Q1 2021 May 17, 2021	SELL	$72.16 - $117.4 $1.76 Million - $2.86 Million	-24,400 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$38.09 - $100.95 $167,596 - $444,180	4,400 Added 22.0%	24,400 $2.22 Million
Q3 2020 Nov 16, 2020	SELL	$30.41 - $40.5 $2.46 Million - $3.28 Million	-81,000 Reduced 80.2%	20,000 $800,000
Q1 2020 May 15, 2020	BUY	$17.28 - $31.88 $17,280 - $31,880	1,000 Added 1.0%	101,000 $2.24 Million
Q4 2019 Feb 13, 2020	BUY	$13.39 - $20.73 $1.34 Million - $2.07 Million	100,000 New	100,000 $1.96 Million

190

123M

15K

14K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $340M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.